‘A World in Disorder’

14 September 2020, GENEVA — COVID-19 has taken advantage of a world in disorder, causing catastrophic health, social, and economic consequences and irreparable harm to humanity. The virus has killed close to a million people and many more may die as a result of its impact on health systems, food supplies, and the economy. The…

Details

Guidance balances staph infection prevention in critically ill infants with family contact

NEW YORK (September 14, 2020) — Neonatal intensive care units (NICU) should balance prevention of Staphylococcus aureus infections in critically ill infants with the need for skin-to-skin contact with parents and siblings, according to a Society for Healthcare Epidemiology of America (SHEA) white paper published in the journal Infection Control & Hospital Epidemiology. The paper…

Details

New $5.4 million study to advance understanding of severe coronavirus infection

The University of Liverpool is leading a major new international project to improve our understanding of severe coronavirus infection in humans. Researchers will sequence and analyse samples from humans and animals to create profiles of various coronaviruses, including SARS-CoV-2, which causes COVID-19. The results will help inform the development of new treatments and vaccines to…

Details

BU researchers awarded NIH grant to create new framingham heart study brain aging program

(Boston)—Since 1976, the Framingham Heart Study (FHS)—the longest running multi-generational epidemiological study in the world—has followed participants for incident dementia. The findings have helped to analyze the differences between normal, age-related changes in thinking and disease-related pathological alterations. In addition, the inclusion of many of the original participants’ children and grandchildren (known as the second-…

Details

Older people with early, asymptomatic Alzheimer’s at risk of falls

Falls are the leading cause of fatal injuries in older adults, causing more than 800,000 hospitalizations and about 30,000 deaths in the U.S. every year. Some risk factors are well-known — advanced age, problems with vision or balance, muscle weakness — but an under-recognized factor is early Alzheimer’s disease. Older people in the earliest stages…

Details

Combining two precision medicines can treat drug-resistant cancers

Launching a dual-pronged attack on tumours using a combination of two innovative precision medicines could treat patients with multiple common cancers, a new clinical trial shows. It is the first trial to use the pioneering genetically targeted drug olaparib — already licensed for ovarian, breast and prostate cancer — together with a promising new medicine,…

Details